Controlled substances; regulate sale of nonpsychoactive consumable hemp products by Agriculture Department; require sale of products only in pharmacies; add psychoactive derivatives of hemp as Schedule I drug

SB 1 (Alabama Senate Bill 1) regulates hemp-derived consumable products containing nonpsychoactive cannabinoids like CBD. It requires all such products (e.g., gummies, oils, topicals) to be sold only in pharmacies certified by the Alabama State Board of Pharmacy, starting January 1, 2026. The bill mandates lab testing for safety and potency before sale, limits products to those made from Alabama-grown hemp, and creates a seed-to-sale tracking system managed by the Department of Agriculture. This directly affects pharmacies, hemp manufacturers, and consumers purchasing these products, while excluding vaping products, food items, and medical cannabis.